Cuiping Liu, Ph.D.

Senior Scientist 

Contact: For contact information, search the NIH Enterprise Directory.


Ph.D., Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Languages Spoken: Mandarin


Dr. Liu conducts research and development on nanoparticle vaccine candidates and therapeutic antibodies against coronaviruses and other infections pathogens. She is also responsible for standardizing assays and assay development, including but not limited to ELISA, autoreactivity assays of monoclonal antibodies, and binding assays. In addition, she also oversees protein production with low endotoxin levels at the Virology Core.